Newsroom

With the Covid-19 pandemic causing ventilator shortages around the globe, three biomedical engineering graduates from the University of South Florida are receiving national recognition for their efforts to mitigate the scarcity of these lifesaving machines.

A new $13.3 million contract from the NIH's Rapid Acceleration of Diagnostics (RADx) initiative will enable the David Geffen School of Medicine at UCLA to expand its capacity to process COVID-19 tests.

Engineers developed a way to grow tiny replicas of the pancreas, using either healthy or cancerous pancreatic cells. Their models could help researchers develop and test potential drugs for pancreatic cancer.

As mice watched movies, scientists watched their brains to see how vision could be represented reliably. The answer is that consistency in representation is governed by a circuit of inhibitory neurons. Source: The Picower Institute for Learning and Memory at MIT.

Equipped with a color 3D camera, an inertial measurement sensor, and its own on-board computer, a newly improved robotic cane could offer blind and visually impaired users a new way to navigate indoors. Development of the device was co-funded by NIBIB the NEI. Source: National Eye Institute.

Researchers have developed a capsule that can carry large protein drugs, such as monoclonal antibodies, and inject them directly into the lining of the stomach.

The human body can be genetically inclined to attack its own cells, destroying the beta cells in the pancreas that make insulin, which helps convert sugar into energy. Called Type 1 diabetes, this disorder can occur at any age and can be fatal if not carefully managed with insulin shots or an insulin pump to balance the body's sugar levels.

A Rice University bioengineer and her Brown School of Engineering team were awarded an NIH grant to create gene activity sensors and activators that hold unmatched potential for the treatment of infectious diseases, diabetes, genetic disorders, and cancer. Source: AZO Life Sciences

Estimates developed by PHICOR, a public health research group, suggest that more than 40 percent of U.S. residents may not be sufficiently protected against the Delta variant. Source: New York Times. New York Times.